Search for: "CASE V. HATCH"
Results 81 - 100
of 1,020
Sorted by Relevance
|
Sort by Date
17 Dec 2008, 5:54 am
By Donald Zuhn --Last week, the Federal Circuit affirmed a finding of exceptionality and award of $16.8 million in attorneys fees by the District Court for the Southern District of New York in a case involving two Hatch-Waxman challenges to U.S. [read post]
8 Jul 2012, 8:58 pm
Lupin and AstraZeneca v. [read post]
29 Mar 2007, 9:27 pm
By Sherri Oslick --- In a case testing the interplay between terminal disclaimers and patent term extensions under the Hatch-Waxman Act, the Federal Circuit, in affirming the judgment of the district court, held that patent term extensions could - nay should - be applied to terminally disclaimed patents, leaving Merck's... [read post]
21 Apr 2008, 2:52 pm
Labs., Ltd. v. [read post]
22 Nov 2013, 2:40 pm
Magistrate Judge Burke has issued a report and recommendation regarding claim construction in a Hatch-Waxman case involving the drug deferasirox, known by the brand name Exjade. [read post]
21 Aug 2009, 2:40 pm
The mock trial, Newark Branded Pharmaceuticals v. [read post]
22 Aug 2014, 8:15 pm
-- Examining the Top 3 Pre-Suit Due Diligence Issues Counsel on Both Sides Should Be Evaluating In Anticipation of a Paragraph IV Suit • The Expansion of the Hatch Waxman Safe Harbor -- Addressing HOW Recent Developments in the Evolution of Case Law Are Impacting Litigation Approaches to Paragraph IV Disputes • PTO v.... [read post]
21 Feb 2007, 1:22 pm
In Marrama v. [read post]
24 Jun 2020, 8:52 am
The court today denied two en banc petitions: Biogen International GmbH v. [read post]
25 Mar 2013, 2:10 pm
I attended the Supreme Court argument in FTC v. [read post]
3 Jul 2018, 7:13 am
(Opinion for the court, Stoll, J.), a case arising under the Hatch-Waxman Act. [read post]
27 Jul 2012, 9:30 am
Last year the United States Supreme Court held in Pliva, Inc. v. [read post]
15 Sep 2008, 7:22 pm
More on Janssen Pharmaceutica, N.V. v. [read post]
5 Dec 2011, 10:38 am
In Caraco Pharmaceutical Laboratories, Ltd v. [read post]
2 Aug 2013, 8:58 pm
The conference will allow attendees to: • Devise strategies relative to the use of new PTO proceedings such as IPR in Hatch-Waxman litigation; • Understand how new 271(e)(1) controversies under Claussen and Momenta may undo Roche v. [read post]
23 Jan 2011, 12:35 pm
United States v. [read post]
24 Aug 2021, 2:10 am
GSK v. [read post]
29 Apr 2010, 6:37 pm
Enter Stengart v. [read post]
2 Sep 2009, 1:05 am
In Martin v. [read post]
11 Sep 2012, 5:30 am
Last week the Federal Circuit decided the case of Santarus, Inc. v. [read post]
